References
- BanghamADStandishMMWatkinsJCDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol19651312382525859039
- MaurerNFenskeDBCullisPRDevelopments in liposomal drug delivery systemsExpert Opin Biol Ther20011692394711728226
- BoermanOCLavermanPOyenWJCorstensFHStormGRadiolabeled liposomes for scintigraphic imagingProg Lipid Res200039546147511082507
- AllenTMCullisPRDrug delivery systems: entering the mainstreamScience200430356651818182215031496
- DuncanRGasparRNanomedicine(s) under the microscopeMol Pharm2011862101214121974749
- GabizonAAStealth liposomes and tumor targeting: one step further in the quest for the magic bulletClin Cancer Res20017222322511234871
- LiSDHuangLStealth nanoparticles: high density but sheddable PEG is a key for tumor targetingJ Control Release2010145317818120338200
- TiroshOBarenholzYKatzhendlerJPrievAHydration of polyethylene glycol-grafted liposomesBiophys J1998743137113799512033
- ZhaoWZhuangSQiXRComparative study of the in vitro and in vivo characteristics of cationic and neutral liposomesInt J Nanomedicine201163087309822163162
- GrefRLuckMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
- HerringsonTPAltinJGEffective tumor targeting and enhanced anti-tumor effect of liposomes engrafted with peptides specific for tumor lymphatics and vasculatureInt J Pharm20114111–220621421443937
- TorchilinVPTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
- LattinJRBelnapDMPittWGFormation of eLiposomes as a drug delivery vehicleColloids Surf B Biointerfaces2012899310021962853
- AshleyCECarnesECPhillipsGKThe targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayersNat Mater201110538939721499315
- LiZBChenKChenX(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin α(v)β(3) expressionEur J Nucl Med Mol Imaging20083561100110818204838
- BarrettTBrechbielMBernardoMChoykePLMRI of tumor angiogenesisJ Magn Reson Imaging200726223524917623889
- FerraraNKerbelRSAngiogenesis as a therapeutic targetNature2005438707096797416355214
- WeidnerNSempleJPWelchWRFolkmanJTumor angiogenesis and metastasis – correlation in invasive breast carcinomaN Engl J Med19913241181701519
- GriffioenAWMolemaGAngiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammationPharmacol Rev200052223726810835101
- HaubnerRWesterHJWeberWANoninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomographyCancer Res20016151781178511280722
- DesgrosellierJSChereshDAIntegrins in cancer: biological implications and therapeutic opportunitiesNat Rev Cancer201010192220029421
- HelbokADecristoforoCDobrozemskyGRadiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometalsJ Liposome Res201020321922719863193
- MarikJTartisMSZhangHLong-circulating liposomes radiolabeled with [18F]fluorodipalmitin ([18F]FDP)Nucl Med Biol200734216517117307124
- TsaiCCChangCHChenLCBiodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis miceInt J Nanomedicine201162607261922114492
- PetersenALBinderupTJolckRIPositron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse modelJ Control Release2012160225426322245688
- JonasdottirTJFisherDRBorrebaekJBrulandOSLarsenRHFirst in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agentAnticancer Res2006264B2841284816886603
- HenriksenGSchoultzBWMichaelsenTEBrulandOSLarsenRHSterically stabilized liposomes as a carrier for alpha-emitting radium and actinium radionuclidesNucl Med Biol200431444144915093814
- BardDRKnightCGPage-ThomasDPEffect of the intra-articular injection of lutetium-177 in chelator liposomes on the progress of an experimental arthritis in rabbitsClin Exp Rheumatol1985332372424053442
- McQuarrieSMercerJSymeASureshMMillerGPreliminary results of nanopharmaceuticals used in the radioimmunotherapy of ovarian cancerJ Pharm Pharm Sci200574293415850546
- Mougin-DegraefMBourdeauCJestinEDoubly radiolabeled liposomes for pretargeted radioimmunotherapyInt J Pharm20073441–211011717592745
- RojasSGispertJDMartinRBiodistribution of amino-functionalized diamond nanoparticles In vivo studies based on 18F radionuclide emissionACS Nano2011575552555921657210
- NachmanRLLeungLLComplex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogenJ Clin Invest19826922632696460044
- FrakerPJSpeckJCJrProtein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3α,6α-diphenylglycolurilBiochem Biophys Res Commun1978804849857637870
- HaubnerRWeberWABeerAJNoninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGDPLoS Med200523e7015783258
- SuWWangHWangSPEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targetingInt J Pharm20124261–217018122266537
- HoligPBachMVolkelTNovel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cellsProtein Eng Des Sel200417543344115235124
- QinJChenDHuHQiaoMZhaoXChenBBody distribution of RGD-mediated liposome in brain-targeting drug deliveryYakugaku Zasshi200712791497150117827930
- HelbokARanggerCVon GuggenbergETargeting properties of peptide-modified radiolabeled liposomal nanoparticlesNanomedicine20128111211821645641
- FalcianiCAccardoABrunettiJTarget-selective drug delivery through liposomes labeled with oligobranched neurotensin peptidesChem Med Chem20116467868521370475
- TorchilinVPKlibanovALHuangLO’DonnellSNossiffNDKhawBATargeted accumulation of polyethylene glycol-coated immunoliposomes in infarcted rabbit myocardiumFASEB J199269271627191612296
- LiSGoinsBZhangLBaoANovel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imagingBioconjug Chem5222012 [Epub ahead of print.]
- DuSLPanHLuWYWangJWuJWangJYCyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in ratsJ Pharmacol Exp Ther2007322256056817510318
- ShokeenMPresslyEDHagoolyAEvaluation of multivalent, functional polymeric nanoparticles for imaging applicationsACS Nano20115273874721275414
- JiangJYangSJWangJCSequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicinEur J Pharm Biopharm201076217017820600887
- AccardoAMansiRMoriscoAPeptide modified nanocarriers for selective targeting of bombesin receptorsMol Biosyst20106587888720567774
- MoriAKlibanovALTorchilinVPHuangLInfluence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivoFEBS Lett199128422632662060647
- LehtinenJMagarkarAStepniewskiMAnalysis of cause of failure of new targeting peptide in PEGylated liposome: molecular modeling as rational design tool for nanomedicineEur J Pharm Sci201246312113022381076
- MontetXFunovicsMMontet-AbouKWeisslederRJosephsonLMultivalent effects of RGD peptides obtained by nanoparticle displayJ Med Chem200649206087609317004722
- LavermanPBrouwersAHDamsETPreclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid doseJ Pharmacol Exp Ther20002933996100110869403
- MaheraniBArab-TehranyEKheirolomoomAReshetovVStebeMJLinderMOptimization and characterization of liposome formulation by mixture designAnalyst2012137377378622158519
- BrinkhuisRPStojanovKLavermanPSize dependent biodistribution and SPECT imaging of (111)In-labeled polymersomesBioconjug Chem4122012 [Epub ahead of print.]
- ZhaoHWangJCSunQSLuoCLZhangQRGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancerJ Drug Target2009171101819016068
- LestiniBJSagnellaSMXuZSurface modification of liposomes for selective cell targeting in cardiovascular drug deliveryJ Control Release2002781–323524711772464
- KnopKHoogenboomRFischerDSchubertUSPoly(ethylene glycol) in drug delivery: pros and cons as well as potential alternativesAngew Chem Int Ed Engl201049366288630820648499